Pharma co Ind-Swift in talks Carlyle, CX Partners, Advent to raise Rs.1,000-Cr

Chandigarh-based pharmaceutical company Ind-Swift Laboratories is in separate talks with private equity investors CX Partners, Advent International and Carlyle Group to raise INR 1,000 crore in exchange for a large minority stake after it failed to complete the sale process with PI Industries. Ind-Swift had called off the business transfer agreement with PI Industries to sell a unit of the company. Jefferies is running a formal process on behalf of the company.